Clinical Trial Update: Pathobiomes in Gut of Critically Ill Patients

View source ↗

Summary

An ongoing University of Chicago clinical trial is investigating gut pathobiomes in critically ill patients, with participant recruitment currently open.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudomonas Aeruginosa Infection

Snippet

Sponsor: University of Chicago | Conditions: Pseudomonas Aeruginosa | Status: RECRUITING